Approximately 300,000 children from infancy to age 14 are diagnosed with cancer worldwide every year [1]. Although cure rates for some pediatric cancers have increased to about 80% in recent [….]
Developing medication, devices, and products for children is not a matter of “shrinking” down the adult version. Delivering solutions to our littlest patients requires a long-term approach that deliberately centers [….]
Q&A With BeneVir Co-Founder and COO, Katherine Sacksteder, PhD – The Path to a Landmark Acquisition (Part 1) October 9, 2018 This has been a year marked by many notable biotech [….]
